A detailed history of Capital International Investors transactions in Legend Biotech Corp stock. As of the latest transaction made, Capital International Investors holds 2,224,388 shares of LEGN stock, worth $75.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,224,388
Previous 2,162,711 2.85%
Holding current value
$75.8 Million
Previous $95.8 Million 13.16%
% of portfolio
0.02%
Previous 0.02%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$43.55 - $59.88 $2.69 Million - $3.69 Million
61,677 Added 2.85%
2,224,388 $108 Million
Q2 2024

Aug 13, 2024

SELL
$39.5 - $57.22 $725,338 - $1.05 Million
-18,363 Reduced 0.84%
2,162,711 $95.8 Million
Q1 2024

May 14, 2024

BUY
$55.06 - $69.99 $19.6 Million - $24.9 Million
356,387 Added 19.53%
2,181,074 $122 Million
Q4 2023

Feb 13, 2024

SELL
$57.25 - $69.74 $464,641 - $566,009
-8,116 Reduced 0.44%
1,824,687 $110 Million
Q3 2023

Nov 13, 2023

SELL
$63.16 - $76.5 $1.84 Million - $2.23 Million
-29,206 Reduced 1.57%
1,832,803 $123 Million
Q2 2023

Aug 11, 2023

SELL
$46.28 - $75.01 $4.1 Million - $6.65 Million
-88,675 Reduced 4.55%
1,862,009 $129 Million
Q1 2023

May 15, 2023

SELL
$43.42 - $57.37 $9.5 Million - $12.6 Million
-218,790 Reduced 10.08%
1,950,684 $94.1 Million
Q4 2022

Feb 14, 2023

SELL
$38.8 - $55.46 $27.7 Million - $39.6 Million
-713,286 Reduced 24.74%
2,169,474 $108 Million
Q3 2022

Nov 14, 2022

SELL
$38.15 - $57.1 $6.15 Million - $9.2 Million
-161,206 Reduced 5.3%
2,882,760 $118 Million
Q2 2022

Aug 15, 2022

BUY
$33.54 - $55.0 $7.82 Million - $12.8 Million
233,229 Added 8.3%
3,043,966 $167 Million
Q1 2022

May 16, 2022

BUY
$31.02 - $48.18 $364,640 - $566,355
11,755 Added 0.42%
2,810,737 $102 Million
Q4 2021

Feb 14, 2022

BUY
$41.14 - $56.98 $4.65 Million - $6.45 Million
113,131 Added 4.21%
2,798,982 $130 Million
Q2 2021

Aug 16, 2021

BUY
$25.8 - $41.09 $52.1 Million - $83 Million
2,019,833 Added 303.27%
2,685,851 $110 Million
Q1 2021

May 14, 2021

SELL
$23.55 - $32.4 $649,273 - $893,268
-27,570 Reduced 3.97%
666,018 $19.3 Million
Q2 2020

Aug 14, 2020

BUY
$36.1 - $42.56 $25 Million - $29.5 Million
693,588 New
693,588 $29.5 Million

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $5.71B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Capital International Investors Portfolio

Follow Capital International Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Investors with notifications on news.